Pakistan DRPA To Form Panel To Address Drug Maker Complaints
This article was originally published in PharmAsia News
Executive Summary
Pakistan's drug regulator decided as one of its first acts to form a committee to address a long list of complaints by the nation's drug makers, including one about large fee increases.